The Ptk2-Pma1 pathway enhances tolerance to terbinafine in Trichophyton rubrum
Antimicrobial Agents and Chemotherapy · 02.05.2024 · 68 (5)
DOI: 10.1128/aac.01609-23 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, erschienen am 02.05.2024. Verfasst von Masaki Ishii und 5 weiteren Autor:innen. Beteiligte Einrichtung: Research Institute of Pharmaceutical Sciences, Faculty of Pharmacy, Musashino University, Tokyo, Japan. Hauptthemen laut MEDLINE: Terbinafine, Antifungal Agents, Saccharomyces cerevisiae, Drug Resistance, Fungal. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MEXT | Japan Society for the Promotion of Science (JSPS), Takeda Science Foundation (TSF).
Abstract (Originalsprache)
The increasing prevalence of dermatophyte resistance to terbinafine, a key drug in the treatment of dermatophytosis, represents a significant obstacle to treatment. Trichophyton rubrum is the most commonly isolated fungus in dermatophytosis. In T. rubrum , we identified TERG_07844, a gene encoding a previously uncharacterized putative protein kinase, as an ortholog of budding yeast Saccharomyces cerevisiae polyamine transport kinase 2 (Ptk2), and found that T. rubrum Ptk2 (TrPtk2) is involved in terbinafine tolerance. In both T. rubrum and S. cerevisiae , Ptk2 knockout strains were more sensitive to terbinafine compared with the wild types, suggesting that promotion of terbinafine tolerance is a conserved function of fungal Ptk2. Pma1 is activated through phosphorylation by Ptk2 in S. cerevisiae . Overexpression of T. rubrum Pma1 (TrPma1) in T. rubrum Ptk2 knockout strain (ΔTrPtk2) suppressed terbinafine sensitivity, suggesting that the induction of terbinafine tolerance by TrPtk2 is mediated by TrPma1. Furthermore, omeprazole, an inhibitor of plasma membrane proton pump Pma1, increased the terbinafine sensitivity of clinically isolated terbinafine-resistant strains. These findings suggest that, in dermatophytes, the TrPtk2-TrPma1 pathway plays a key role in promoting intrinsic terbinafine tolerance and may serve as a potential target for combinational antifungal therapy against terbinafine-resistant dermatophytes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Institute of Pharmaceutical Sciences, Faculty of Pharmacy, Musashino University, Tokyo, Japan.
- Teikyo University Institute of Medical Mycology, Teikyo University, Tokyo, Japan.
- Asia International Institute of Infectious Disease Control, Teikyo University, Tokyo, Japan.
- Department of Dermatology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
- Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.
ORCID-Profile: Masaki Ishii, Tsuyoshi Yamada, Shinya Ohata
Förderung
- MEXT | Japan Society for the Promotion of Science (JSPS)
- Takeda Science Foundation (TSF)
Zitieren
APA
Ishii, M., Yamada, T., Ishikawa, K., Ichinose, K., Monod, M., & Ohata, S. (2024). The Ptk2-Pma1 pathway enhances tolerance to terbinafine in Trichophyton rubrum. Antimicrobial Agents and Chemotherapy, 68(5). https://doi.org/10.1128/aac.01609-23
Vancouver
Ishii M, Yamada T, Ishikawa K, Ichinose K, Monod M, Ohata S. The Ptk2-Pma1 pathway enhances tolerance to terbinafine in Trichophyton rubrum. Antimicrobial Agents and Chemotherapy. 2024;68(5). doi:10.1128/aac.01609-23
BibTeX
@article{Ishii2024,
author = {Ishii, Masaki and Yamada, Tsuyoshi and Ishikawa, Kazuki and Ichinose, Koji and Monod, Michel and Ohata, Shinya},
title = {The Ptk2-Pma1 pathway enhances tolerance to terbinafine in Trichophyton rubrum},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2024},
volume = {68},
number = {5},
doi = {10.1128/aac.01609-23}
}
EUVIMED